Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Bryan J Schneider, Jarushka Naidoo, Bianca D Santomasso, Christina Lacchetti, Sherry Adkins, Milan Anadkat, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau, Marianne J Davies, Marc S Ernstoff, Leslie Fecher, Monalisa Ghosh, Ishmael Jaiyesimi, Jennifer S Mammen, Aung Naing, Loretta J Nastoupil, Tanyanika Phillips, Laura D Porter, Cristina A Reichner, Carole Seigel, Jung-Min Song, Alexander Spira, Maria Suarez-Almazor, Umang Swami, John A Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S Weber, Pauline Funchain, Kathryn Bollin
To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy
문서, 2021